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Objective: To determine whether 155 circulating metabolic measures relevant to lifestyle 
and metabolic health are associated with sperm parameters, as measured by concentration, 
motility and total motile sperm count (TMSC). 
Study design: Cross-sectional.  
Setting: University Hospital. 
Patients: 325 men prospectively recruited between April 1, 2017 and March 31, 2019. 
Intervention(s): Non-fasting serum lipids, lipoprotein subclasses, and low-molecular weight 
metabolites (including amino acids, glycolysis and inflammatory markers) were quantified by 
NMR spectroscopy. Detailed demographic, lifestyle, fertility and medical history and semen 
analysis. 
Main Outcome Measure(s): Associations of serum metabolic profiles with sperm 
parameters. 
Results: Participants were mean 37.2 (SD 5.7) years, with a median sperm concentration of 
35 million/ml (IQR 15, 69) and median motility of 53% (IQR 42,67). 76% of men had a 
TMSC >15 Million, 10% 5-15 Million and 14% <5 Million. In both univariate and 
confounder adjusted analyses an extensive range of lipids and lipoproteins, glycolysis related 
metabolites, amino acids, ketone bodies, creatinine or albumin, did not show strong statistical 
evidence of associated with sperm concentration, motility, or the odds of having a reduced or 
low TMSC (all PBonferroni > 0.0029).  Higher levels of glycolysis metabolites and ketone 
bodies were associated with increased odds of TMSC <15M compared with ≥15M (odds 
ratios of ~1.2 to 1.3), and several lipids/lipoprotein concentrations appeared to protect against 
very low TMSC (<5M compared with ≥5M) with odds ratios of ~0.8 or greater.  
Conclusion: Several metabolites exhibit potentially clinically relevant strength of association 











Despite increasing concern regarding the significant decline in sperm counts over the last few 
decades (1), therapeutic options for male infertility are limited (2). The significant body of 
data to support the concept that oxidative stress (3) and also potentially metabolic 
dysfunction (4) are associated with sperm dysfunction, have driven recent intervention trials 
to primarily focus on preconceptual optimisation of health (2, 5, 6).  
 
Robust identification of additional modifiable and non-modifiable risk factors for poor semen 
quality have however had limited success. For example smoking (7, 8), adiposity (7, 9-12) 
and alcohol excess (7, 13, 14) have all shown non-consistent associations with the risk of 
poor semen parameters. Consequently, advice is primarily based on a “good health advice” 
model, rather than robust evidence for a detrimental effect on semen parameters (15).  An 
alternative approach to identify risk factors for an abnormal semen analysis would be to 
examine circulating metabolites, which may provide insights into downstream factors as well 
as more upstream exposures (16). Detailed metabolic profiling has previously been used to 
explore the metabolic pathways that may underpin phenotypes, including adiposity (17), and 
has been widely used in epidemiological studies to identify novel risk factors for a variety of 
reproductive and pregnancy characteristics (18-22). The application of NMR spectroscopy to 
male infertility has however been limited to primarily small studies (n =29 to 80) which have 
assessed selected metabolites within the sperm metabolome (23-25) or seminal fluid (26-29). 
Alternative metabolomic approaches (liquid chromatography coupled to mass spectrometry 
(LC-MS) or high resolution mass spectrometry (LC-HRMS) or gas chromatography-mass 
spectrometry (GC-MS)) have been undertaken on plasma, serum, seminal plasma and urine, 
but studies have been of varying size (n=30 to 260), primarily used a case-control design with 




conventional discovery based metabolomic approaches that have not provided absolute 
quantities (30-33).  
 
The aim of the current study was to undertake an exploratory analysis of the association of 
155 circulating metabolic measures with sperm parameters. These measures were profiled by 
a high throughput cost efficient NMR platform, covering a range of metabolic pathways, 
predominantly a lipidome, including lipoprotein lipids, fatty acids, as well as some amino 





Material and methods 
Study Design and Participants 
Cross-sectional study of men aged 18 to 55 who presented to Glasgow Royal Infirmary, UK 
between 1 April 2017 and 31 March 2019 for assessment prior to assisted conception. A total 
of 326 men were recruited and of these 325 (99%) had complete data on semen parameters 
and were included in the analyses presented in this paper. 
 
The study was conducted according to ICH Guideline for good clinical practice, the 
Declaration of Helsinki and the Convention of the Council of Europe. All men provided 
written informed consent. The study protocol was approved prior to study initiation by the 
relevant institutional review boards (see Supplementary Material).  
 
Study procedures: 
Demographic, lifestyle, fertility and medical history was obtained by self-reported 
questionnaire and clinical data by linkage to electronic medical records. Blood samples were 
taken for NMR analyses and immediately spun and frozen at −80 °C. All NMR assays 
completed for this study were undertaken within 1 year of storage and with no previous 
freeze/thaw cycles.  
 
Semen analysis: 
The semen sample was provided in the morning of the same day as the blood sample for 
NMR analyses. Semen analysis was completed utilizing the World Health Organisation 
guidelines (34). The men were advised to produce a semen sample after 2–3 days of sexual 
abstinence. The semen sample was collected in the hospital or at home in the morning 




at 30 minute intervals from 0800 to 1000) of the same day as the blood sample for NMR 
analyses were taken (with blood samples taken between 1330 and 1600). Giving a range of 
3.5 hours to 8 hours between ejaculation and the blood sample for NMR analysis. Semen 
volume was measured using a graded tube. The concentration was measured in an Improved 
Neubauer chamber in two replicates and at least 200 spermatozoa counted in each replicate, 
at a magnification of 200×. Where the difference between the counts was greater than 
acceptable based on the 95% confidence intervals, the first two values were discarded, and 
two fresh dilutions of semen prepared and assessed. Motility was scored manually, as 
percentages of (A) fast forward progressive, (B) slow forward progressive, (C) non-
progressive and (D) immotile spermatozoa in 200 spermatozoa in at least five power fields 
per replicate, according to recommendations (34). The Glasgow Royal Infirmary clinic from 
which study participants were recruited, collaborates in a nationwide quality control system 
organized by the UK National External Quality Assessment Scheme (NEQAS). For those 
men where the initial and repeat sample exhibited azoospermia a surgical sperm retrieval was 
performed, and the sample evaluated prior to cryopreservation.  
 
TMSC groups 
The men were grouped according to the TMSC, calculated by multiplying the sample volume 
by the concentration and the percentage of A and B motility divided by 100%. Three groups 
were created: men with TMSC > 15 million (M); men with a TMSC of 5 to 15M; and men 
with TMSC of <5M (including those with azoospermia) (35-37)  
 
NMR protocol  
Profiling of 155 lipid and metabolite measures was performed by a high-throughput targeted 




platform applies a single experimental setup, which allows for the simultaneous 
quantification of routine lipids, 14 lipoprotein subclasses and individual lipids transported by 
these particles, multiple fatty acids, glucose, various glycolysis precursors, ketone bodies, and 
amino acids in absolute concentration units.  The NMR-based metabolite quantification is 
achieved through measurements of three molecular windows from each serum sample. Two 
of the spectra (LIPO and LMWM windows) are acquired from native serum and one 
spectrum from serum lipid extracts (LIPID window). The NMR spectra were measured using 
Bruker AVANCE III spectrometer operating at 600 MHz. Measurements of native serum 
samples and serum lipid extracts are conducted at 37OC and 22OC, respectively. Details of 
this platform have been published previously (16, 38, 39) and it has been widely applied in 
genetic and observational epidemiological studies (18, 19, 40-44). Further details of the 
platform are provided in the Supplemental Material (Text box; Table S1 and Figure S1). 
 
Metabolite quantification and quality control 
The NMR spectra were analysed for absolute metabolite quantification (molar concentration) 
in an automated fashion. For each metabolite, a ridge regression model was applied for 
quantification in order to overcome the problems of heavily overlapping spectral data. In the 
case of the lipoprotein lipid data, quantification models were calibrated using high 
performance liquid chromatography methods, and individually cross-validated against NMR-
independent lipid data. Low-molecular-weight metabolites, as well as lipid extract measures, 
were quantified as mmol/l based on regression modelling calibrated against a set of manually 
fitted metabolite measures. The calibration data are quantified based on iterative line-shape 
fitting analysis using PERCH NMR software (PERCH Solutions Ltd., Kuopio, Finland). 




experimental variation in the lipid extraction protocol. Therefore, serum extract metabolites 
are scaled via the total cholesterol as quantified from the native serum LIPO spectrum.  
 
With respect to controls, samples were analysed in batches of 96 containing two control 
samples; a pooled serum control and a synthetic control. Aliquots of these same controls were 
used for the whole analysis, as well as other analyses carried out in the same time frame. This 
allowed consistency of results to be monitored to check that no batch of sample had degraded 
overly compared to others, sample preparation was consistent and that the NMR instruments 
produced stable results. 
 
Assessment of potential confounders 
Age, BMI, educational attainment, ethnicity, family history of cardiovascular disease 
(defined as first degree relative affected), physical activity, alcohol intake, smoking status, 
and duration of infertility were considered as potential confounders because they plausibly 
influence both semen parameters and the NMR metabolites (45). All confounders were 
obtained by a questionnaire or from medical notes when the men were originally recruited.  
 
Statistical analysis  
All analyses were conducted using Stata (Version 15.1) and R version 3.4.2 (R Foundation 
for Statistical Computing, Vienna, Austria). An analysis plan was written in June 2019. 
Characteristics were summarized as number and percentage, total range, mean, standard 
deviation, median, and 25th and 75th quantiles (IQR) as appropriate. Multivariable linear 
regression was used to examine the associations of serum metabolic profiles (treated as 
exposures) with % progressive motility and sperm concentration (treated as outcomes). 




metabolic measures were scaled to standard deviation (SD) units (by subtracting the mean 
and dividing by the standard deviation of all men included in the analyses). This scaling 
allows easy comparison of multiple metabolic measures with different units or with large 
differences in their concentration distributions. Sperm concentration (natural log transformed) 
and progressive motility were also scaled to SD units in the same way as the metabolites. 
Multivariable logistic regression was used to examine the associations of the serum metabolic 
profiles (treated as exposures) with TMSC. Two analyses were undertaken: (i) exploring the 
odds of having a low TMSC (<15M) compared to a normal TMSC (i.e. >15M) and (ii) 
exploring the odds of having a very low TMSC (<5M) compared to a low or normal TMSC 
(i.e. ≥5M). We adjusted for all a priori selected confounders (age, ethnicity, education, family 
history of cardiovascular disease, BMI, physical activity, alcohol, smoking, and duration of 
infertility) in both the multivariable linear and logistic regression analyses.  
 
Additional sensitivity analyses 
In addition to presenting our main results as difference in mean metabolite in SD units per SD 
of concentration or motility, we also present the full results (confounder adjusted) in the 
metabolite, concentration and motility original units in Supplementary Material 
(Supplemental Tables 5 and 6). We repeated our main analyses on those men with a known 
male factor cause of infertility (N=66 (20% of the cohort)) and compared these associations 
to those men with an unknown or known female partner cause of infertility (N=258 (79%)) 
(Supplemental Figures 5 to 10). We wished to compare the point estimates in this group to 
the results of the whole cohort to provide some indication as to whether our results might be 
driven by the cause of infertility or potentially generalisable to men of reproductive age 
without infertility. We compared the magnitudes of the results in men who were going to 




cause of infertility with those of the whole cohort using a scatterplot. As 99% of the men 
recruited had full data on semen parameters and at least one metabolite, with <1% of these 
having missing covariable data (see Table 1) we did not need to undertake any additional 
analyses to explore potential biases due to missing data.  
 
Accounting for multiple testing 
Due to the correlated nature of the metabolic biomarkers, over 95% of the variation in the 
155 metabolic biomarkers was explained by 15 principal components. Therefore, multiple 
testing correction, accounting for 15 independent tests using the Bonferroni method, resulted 
in PBonferroni < 0.0033 (0.05/15) being denoted as statistically significant.  
Results 
Three hundred and twenty-five men (99% of the 326 recruited) with available semen analysis 
and metabolomics evaluation were included in the study. Characteristics of the participants 
are shown in Table 1. Mean (SD) age of the men was 37.2 (5.7) years with a mean (SD) BMI 
of 25.2 (3) Kg/m2. The majority (92%) were white European, with over 50% having a 
university degree, 30% being ever smokers, 69% reporting exercising equal to or more than 
3-4 times per week, 47% having a family history of cardiovascular disease and median 
alcohol consumption being 4 units per week. For 54% of the men the cause of them and their 
partner requiring referral for assisted conception was unexplained and for 26% the cause was 
related to their female partner; the source of requiring assisted conception was deemed due to 
sperm / male causes in 20% of the men included in this study. Sample production was by 
masturbation for 98%, with 6 men requiring surgical sperm retrieval. The median sperm 
concentration was 35 Million per ml (IQR 15, 69 Million per ml) and median progressive 
motility was 53% (IQR 42, 67 %) in the whole sample. These differed by cause of infertility, 




(IQR 1.4, 23 Million per ml) and the median progressive motility being 32.5% (IQR 15,58) 
and equivalent values in men where the cause of infertility was unknown or a known cause in 
their female partner being 42 Million per ml (IQR 23, 84) and 55% (IQR 46, 68). 
 
The unadjusted associations of sperm concentration, motility and TMSC with confounders 
are shown in Supplemental Tables 2, 3, and 4 respectively. With the exception of established 
male factor infertility having a negative association with sperm concentration, motility and 
TMSC there was no clear evidence for associations of baseline demographic or lifestyle 
characteristics, including BMI, with semen parameters.   
 
The adjusted associations between sperm concentration and progressive motility and the 
respective metabolomics measures are presented in Figure 1. With the unadjusted analyses 
for sperm concentration and progressive motility presented in Supplemental Figures S2.  
Histidine was the only metabolite with Bonferroni corrected statistical evidence of an 
association with motility in the unadjusted analyses and there was no statistical evidence of 
any metabolites associating with sperm concentration. Whilst all of the associations were 
imprecisely estimated (i.e. with wide confidence intervals), most of the point estimates for the 
lipids were very close to the null, except for very large, large and medium HDL particle 
concentrations and apolipoprotein A-1 which had inverse associations with point estimates of 
~ -0.1SD with sperm motility per 1SD higher lipid. Creatinine also has a point estimate of 
0.1SD, showing a positive association with sperm motility, though again with wide 
confidence intervals and not reaching the Bonferroni corrected statistical significance. In 
results adjusted for confounders (Figure 1) the associations showed very little difference to 
the unadjusted results. The adjusted association for histidine with motility was 0.12 SD per 1 




than the Bonferroni corrected value at 0.02. In contrast, lactate showed a negative association 
with motility (-0.11 SD in sperm motility (95%CI -0.23, 0.01) per 1 SD increase in lactate 
concentration) but no association with concentration.  
 
Analyses of the associations of metabolites with odds of a low TMSC compared with a 
healthy count (Figure 2) and of odds of a very low TMSC compared to either a low or healthy 
count (Figure 3) did not have statistical (Bonferroni corrected) support for any associations, 
though these analyses have less power than with the continuously measured outcomes and 
wide confidence intervals. Point estimates for adjusted associations were close to the null for 
all lipids, lipoproteins and fatty acids. For glucose, lactate, pyruvate, both ketone bodies and 
glycoprotein acetyls point estimates suggested positive associations with reduced compared 
to a normal TMSC with odds ratios of ~1.2 and for glycerol a positive association with an 
odds ratio of ~1.3. There was also a point estimate of 0.8 for creatinine with low versus 
normal TMSC.  When comparing TMSC of <5 million to ≥ 5 million the adjusted 
associations for most very small VLDL, IDL and large, medium and small LDL 
concentrations, and some of the cholesterols and triglycerides and phospholipids had point 
estimates of ~0.8 suggesting potentially important reduced odds of a very low sperm count 
with higher levels of these lipids but for which we had limited power to obtain precise 
estimates that excluded the null (Figure 3). Degree of fatty acid unsaturation had a point 
estimate OR of ~0.6 in these analyses and some other metabolites were associated with very 
low TMSC with OR suggestive of a relative increase or decrease in odds of 20% or more. 
 
When analyses were repeated only in those undergoing assisted conception for male factor 
(n=66) as opposed to unexplained or female cause of infertility (n=258), most of the 155 




to be stronger for both concentration and motility (Figures S3 and S4). In those with male 
factor infertility there was evidence of higher phenylalanine associating with higher sperm 
concentration and motility (0.44 SD (95%CI 0.09, 0.80) per 1 SD for both outcomes) 
(Figures S3 and S4). Comparing all point estimates across all 155 metabolites between those 
with male factor infertility and those with female or unknown causes showed poor 
consistency between the two groups (Figure 4; goodness of fit statistic R2 = 0.1 for sperm 
concentration and 0.03 for motility). Indeed most of the associations with sperm 
concentration were in the opposite directions between the two groups (slope = -0.92 (95% CI 
–0.48, 1.36)), including for associations of phenylalanine and creatinine which associated 
positively with concentration in those with male cause infertility and weakly inversely in 
those without. For sperm motility many associations were also directionally inconsistent 
(weak positive slope 0.35 (95% CI 0.004, 0.70)); associations of both phenylalanine and 
creatinine were positively associated with motility, with a stronger association in those with 
male cause fertility than those without (Figure 4). Results were unchanged when the potential 






In this cross-sectional exploratory study of men attending a fertility clinic for evaluation we 
did not identify any associations between circulating metabolites and sperm concentration, 
sperm progressive motility or the risk of a low or very low TMSC on the basis of reaching 
conventional 5% levels of statistical significance after Bonferroni correction for multiple 
testing. However, point estimates suggested some potentially clinically important 
associations. Higher levels of glycolysis metabolites and ketone bodies were associated with 
increased odds of TMSC <15M compared with ≥15M (odds ratios of ~1.2 to 1.3), and several 
lipids/lipoprotein concentrations appeared to protect against very low TMSC (<5M compared 
with ≥5M) with odds ratios of ~0.8 or greater. That this study is unique in exploring these 
associations highlights the importance of funding to undertake larger studies that could 
precisely estimate associations and provide more robust evidence of how large any 
associations are likely to be. Based on a post-hoc power calculation we estimate that a sample 
size of 3,188 would be required at the Bonferroni corrected p-value used in this study to 
detect a 20% relative difference in odds (i.e. OR of 0.8 or 1.2) or larger with 80% power. 
 
A potential role for lipids and semen parameters is plausible as cholesterol is the precursor of 
steroid hormones, including testosterone which is produced in the Leydig cells (46), testicular 
cholesterol has been shown contribute to normal spermatogenesis (47) and cholesterol-fed 
rats and rabbits showed reduced spermatid cell numbers, reduced seminiferous tubules’ 
diameters, and smaller Leydig cell nuclear dimensions (48). However, the association of 
serum lipids and semen parameters has been inconsistent, with some (49) but not all studies 
(47, 50) finding an inverse association with lipids and sperm concentration and / or motility. 
The LIFE study (n=501) which quantified 35 different semen parameters, found that total and 




sperm head morphology defects but not with concentration or motility (51). In the largest 
study to date of healthy individuals (n= 7,920) total cholesterol level was positively 
correlated with total sperm motility and progressive motility, but there was no association 
observed for HDL, LDL, Triglyceride or VLDL with concentration or motility (52). A 
similarly large study, with a comprehensive evaluation of the lipoprotein spectrum as per the 
current study combined with the extensive assessment of semen parameters as per the LIFE 
study would be useful. Further clarification of whether lipoproteins levels in the male 
reproductive tract are regulated locally as per the rat (53), and not through passive diffusion 
from serum would also be useful.  
 
We observed a weak negative association of increasing lactate concentrations with reduced 
motility. Human sperm have been shown to be capable of metabolising 13C labelled glucose 
and pyruvate to lactate via lactate dehydrogenase (54), and that lactate oxidation by lactate 
dehydrogenase isoenzymes has a significant role in energy metabolism during the middle and 
later stages of spermatogenesis (55). Lactate has been shown to have an inhibitory effect on 
sperm motility, in part by acidification of the cytosol (56, 57), but also it has been suggested 
that lactate may inhibit the binding site of lactate dehydrogenase (56). It is possible that 
export of lactate from sperm leads to acidification of the extracellular medium and 
contributes to a reduction in sperm motility. Confirmation that circulating lactate 
concentrations may also have a negative association on sperm motility warrants replication 
given that lactate concentrations increase during acute illness, and other systemic insults but 
also during strenuous exercise (58).   
 
The impact of supplementation with omega-3 fatty acids on semen parameters has been 




with docosahexaenoic (DHA) and eicosapentaenoic acids (EPA) (990 mg/d and 135 mg/d, 
respectively) for 10 weeks demonstrated no effect on sperm parameters but improved sperm 
DNA fragmentation (60). Although supplementation with higher amounts of DHA + EPA 
(0.72 g/d and 1.12 g/d, respectively) led to significant improvements in total sperm count and 
concentration, sperm motility, and morphology (61). However, we were unable to detect any 
robust association with either omega-3 or omega-6 fatty acids and sperm parameters; for 
these exposures all point estimates were close to the null (thought the degree of saturation of 
fatty acids did have a point estimate odds ratio of ~0.8 for TMSC< 5M compared with ≥5M). 
Similarly, although a variety of amino acids, including arginine and cysteine are frequently 
incorporated into anti-oxidant preparations and, have been suggested as a means of 
improving semen parameters and potentially live-birth rates (62), neither branched chain or 
aromatic amino acids were associated with semen parameters. Replication the association of 
histidine with motility would be useful, as it has been suggested that at ejaculation sperm 
chromatin is critically stabilized by salt bridges in which zinc interchelates between thiols 
and possibly the imidazole groups of histidine (63). Low phenylalanine concentrations in 
seminal plasma have previously been reported for oligospermic males (64), however whether 
supplementation is beneficial is unknown.  
 
We did not observe any association with baseline demographics, including adiposity or 
alcohol intake and semen parameters. Previous larger population studies and meta-analyses 
have differed in their findings with respect to whether there is or is not an inverse association 
between adiposity and sperm concentration and motility (7, 9-12). Whether this reflects that 
BMI is a relatively crude marker for adiposity, although it is strongly related to other health 
outcomes including mortality (65), or whether metabolic health rather than adiposity per se 




the NMR platform used in the current study has previously detected differences for a range of 
metabolic disorders including adiposity (17), suggesting that adiposity or mild deviation of 
metabolic health may have a limited impact on crude semen parameters such as concentration 
and motility. Similarly, we did not observe a detrimental effect of alcohol on semen 
parameters, consistent with previous meta-analyses which have suggested that a detrimental 
effect of alcohol seemed to be limited to daily drinkers, whereas occasional drinkers or low 
intake as per our participants were apparently similar to never drinkers (67).  
 
While our findings are of interest, we acknowledge some important limitations, the relatively 
small sample size, and lack of a replication cohort which is why we present the novel 
analyses we have undertaken as exploratory. As noted above we are unable to exclude some 
potentially clinically important associations and have estimated that a sample size of at least 
3,188 would be required to obtain more precise and statistically robust results. Our cohort 
comprised of men presenting to a tertiary infertility service which on average are older than 
the mean age of fathers in the UK during this time period, irrespective of whether this was for 
becoming a farther to their, first, second or other child (37 vs 34 years) and may not be 
generalisable to men at the younger (e.g. < 20 years) or older (e.g. > 60 years) extremes of 
the reproductive lifespan. We included some men with extremely low sperm counts, 
azoospermia and surgical sperm retrieval and those with known female factor infertility and 
although we assessed whether the observed associations differed depending on the cause of 
infertility, our findings may not be generalisable to healthy individuals. Furthermore, that 
men were confirmed (through cotinine breath test) as non-smokers, were of a relatively 
restricted BMI range and largely white European and educated to degree level may have 
introduced a selection bias which have attenuated our results towards the null. A single 




the intraclass coefficient of the parameters assessed is adequate to enable a single sample to 
be used for infertility referral and treatment (2). We used the TMSC thresholds derived by 
Tiegs and colleagues (37), as that study assessed 119,972 semen samples, rather than the 20 
million threshold described by others in much smaller studies (35, 36). We did not assess 
other aspects of sperm function including sperm DNA fragmentation, however, at present 
there is no consensus on the optimal assay methodology or its contribution to prognosis. We 
acknowledge that at present it is unknown whether ejaculation (whether during sex or 
masturbation) alters blood metabolites levels, and future studies of paired pre and post 
ejaculation blood samples would be useful to clarify this. We also acknowledge that the 
metabolic composition of seminal fluid may have influenced sperm function, with several 
studies of seminal fluid suggesting associations of metabolites with semen parameters (26-
29). Similarly repeat metabolite measures across the window of spermatogenesis may further 
inform a potential role of specific metabolites.   Lastly, serum metabolites were measured on 
the day of the semen sample and therefore may not reflect the entire spermatogenic cycle, 
however, previous analyses of short- and long-term repeat 1H NMR measures (<6 months 
and >3 years) have shown good intra-class coefficients supporting that they would be 
representative of exposures of the spermatogenic cycle (39).    
 
Conclusions 
This study provides preliminary data on a range of metabolic pathways and their association 
with semen parameters. While we found most point estimates to be close to the null and few 
associations that met conventional statistical thresholds after adjustment for multiple testing, 
we identified several metabolites that associated with odds of TMSC with potentially of 
important clinical effect sizes (differences in relative odds of 20%) which warrant further 
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Figure 1. Associations of metabolites with sperm concentration and progressive motility 
in men undertaking assisted conception 
Effect sizes per 1 SD in metabolite concentrations and respective 95% confidence intervals 
are shown for sperm concentration (red) and progressive motility (black).  Adjusted for age, 
education, family history of CVD, BMI, physical activity, alcohol (units per week), ever 
smoking, ethnicity and duration of infertility.  
 
Figure 2. Associations of metabolites with odds of having a TMSC less than 15 Million 
compared with greater or equal to 15 million. 
Odds ratio for having a total motile sperm count less than 15 Million and respective 95% 
confidence intervals for each metabolic trait.  Adjusted for age, education, family history of 
CVD, BMI, physical activity, alcohol (units per week), ever smoking, ethnicity and duration 
of infertility.  
 
Figure 3. Associations of metabolites with odds of having a TMSC less than 5 Million 
compared with 5 million or more. 
Odds ratio for having a total motile sperm count less than 5 Million compared with 5 million 
or more and respective 95% confidence intervals for each metabolic trait.  Adjusted for age, 
education, family history of CVD, BMI, physical activity, alcohol (units per week), ever 
smoking, ethnicity and duration of infertility. 
 
Figure 4: Scatterplot of associations between sperm concentration and motility and 
metabolites in those males with female or unknown cause of infertility (N = 398) and 
restricted to males with a reported male partner cause of infertility (N = 66).  
Figure 4a shows associations with concentration by cause of infertility, Figure 4b shows 
associations with motility by cause of infertility. The green dots highlight the individual 
metabolites, with phenylalanine and creatinine highlighted. The grey dashed line reflects the 






Supplemental Figure S1: Stages and methods used for NMR platform metabolic 
measures (adapted from Wurtz et al.(68)) 
 
Supplemental Figure S2. Association of metabolite levels with sperm concentration and 
motility (unadjusted)  
Effect sizes per 1 SD in metabolite concentrations and respective 95% confidence intervals 
are shown for sperm motility (red) and concentration (black).  
 
 
Supplemental Figure S3. Association of metabolite levels with sperm concentration by 
cause of infertility  
Effect sizes per 1 SD in metabolite concentrations and respective 95% confidence intervals 
are shown for sperm motility concentration for male factor infertility (red) and female / 
unexplained infertility (black).  Adjusted for age, education, family history of CVD, BMI, 
physical activity, alcohol (units per week), ever smoking, ethnicity, duration of infertility, and 
primary/secondary infertility. 
 
Supplemental Figure S4. Association of metabolite levels with sperm motility by cause 
of infertility  
Effect sizes per 1 SD in metabolite concentrations and respective 95% confidence intervals 
are shown for sperm concentration for male factor infertility (red) and female / unexplained 
infertility (black).  Adjusted for age, education, family history of CVD, BMI, physical 
activity, alcohol (units per week), ever smoking, ethnicity, duration of infertility, and 

























































Ever smoked: N(%) 97 (30%) 
Alcohol (units per week)  : Median, IQR, 
Range 
4 (2,9) 0-40 
BMI: Mean, SD, Range 25.2 (3.0) 19.4-35.1 




















Family history of cardiometabolic disease: 
N(%) 
153 (47%) 

















Total motile sperm count 
< 5 Million 
5- 15 Million 





% Motile : Median, IQR, Range 53 (42,67) 0-91 
Sperm concentration (M per ml):  Median, 
IQR, Range 





































Figure 4: Scatterplot of associations between sperm concentration and motility and 
metabolites in those males with female or unknown cause of infertility (N = 398) and 
restricted to males with a reported male partner cause of infertility (N = 66).  
Figure 4a shows associations with concentration by cause of infertility, Figure 4b shows 
associations with motility by cause of infertility. The green dots highlight the individual 
metabolites, with phenylalanine and creatinine highlighted. The grey dashed line reflects the 
reference line (slope 1, intercept 0) and the red dashed line is the best line of fit.   
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